Difference between revisions of "Minutes - Medication WG 2021-05-11"
From Health Level 7 Belgium Wiki
KarlienErauw (talk | contribs) |
KarlienErauw (talk | contribs) |
||
| Line 37: | Line 37: | ||
::* the purpose is to achieve the MS | ::* the purpose is to achieve the MS | ||
::* are we going to translate kmehr to FHIR ? lots of risks | ::* are we going to translate kmehr to FHIR ? lots of risks | ||
| − | ::* starting from something completely new: we risk to lose data | + | ::* starting from something completely new: we risk to lose data from the past, we need compatibility |
:: can the care plan be left out from this WG ? | :: can the care plan be left out from this WG ? | ||
* We miss the definition of the MS | * We miss the definition of the MS | ||
::* currently the MS in kmehr is visualised in a document | ::* currently the MS in kmehr is visualised in a document | ||
| + | ::* MS can be the scheme for Vitalink | ||
| + | ::* there is a type/version | ||
| + | * What if an indication/treatment is confidential to one GP, one pharmacist will know of the dipsense of the medication without the indication, what about sharing to the vault | ||
| + | ::* will it be shared to the vault? mechanisms will have to be put in place | ||
| + | ::* permission resource will have to be added | ||
| + | * medication treatment vs medication summary vs medication scheme: there is a lack of detail in the modelling | ||
| + | ::* medication summary : sort of a view/snapshot on the medication | ||
| + | ::* medication scheme: digested scheme of a patient's medications | ||
| + | * kmehr MS with a concept of different medication treatments: what contains the list of medication treatment lines ? the medication treatment | ||
| − | + | * There is a need for examples and compilation to documents | |
| − | + | * Therefore it would be useful to start a list with the examples that we need | |
| − | + | ::* psychiatric medication with privacy settings | |
| − | + | ::* medication having same substance used for different indications and different posologies | |
| − | + | ::* distinction between hospital treatment and home therapy | |
| − | + | ::* interactions between home therapy and psychiatric medication | |
| − | ::* | + | ::* magistral preparations |
| − | ::* | + | ::* need to see clear example of and difference b/w treatments and summary |
| − | + | * Do we need support from pharmacist ? | |
| − | ::* | + | ::* José will ask input from vidis |
| − | ::* | + | ::* Pablo will have a look |
| − | + | ::* Jens will try to provide input | |
| − | ::* | + | ::* Tom H will check |
| − | ::* | ||
| − | |||
| − | |||
| − | |||
| − | ::* José | ||
| − | |||
| − | ::* | ||
| − | ::* | ||
'''Action items for next meeting''' | '''Action items for next meeting''' | ||
::* each one of us to check offline and with his team to continue discussion on treatment lines | ::* each one of us to check offline and with his team to continue discussion on treatment lines | ||
| + | ::* status of approval of medication history : to provide by HL7 Belgium | ||
| − | + | '''Next meeting May 25 at 11AM''' | |
| − | '''Next meeting May | ||
Latest revision as of 10:02, 11 May 2021
Attendees
- Bruno Casneuf
- Dieter Sauvillers
- Elhassan Baazizi
- Hanne Vuegen
- Jean-Louis Maggetto
- Jean-Michel Polfliet
- Jens Penny
- José Costa Teixeira
- Karlien Erauw
- Pablo Christiaens
- Richard Francken
- Robin Bosman
- Tom De Backer
- Tom Henkens
- Will van Norel
Excused/Not present
- Anne Nerenhausen
- Annemieke Vergauwe
- Jan Lenie
- Jeroen De Wilde
- Lars Vanreppelen
- Marc Buckens
- Nils Devos
Agenda
- feedback on the model
Minutes
- Magistral preparations: no update
- What is the purpose and intent of the high level modelling towards the scope of the medication scheme project and exchange of the related MS information, including the outcome
- the purpose of the logical model is having a common understanding what the data means apart from the FHIR modelling
- logical model is perceived as a flow
- What do we want to achieve here ? the MS, the careplan, ...
- the purpose is to achieve the MS
- are we going to translate kmehr to FHIR ? lots of risks
- starting from something completely new: we risk to lose data from the past, we need compatibility
- can the care plan be left out from this WG ?
- We miss the definition of the MS
- currently the MS in kmehr is visualised in a document
- MS can be the scheme for Vitalink
- there is a type/version
- What if an indication/treatment is confidential to one GP, one pharmacist will know of the dipsense of the medication without the indication, what about sharing to the vault
- will it be shared to the vault? mechanisms will have to be put in place
- permission resource will have to be added
- medication treatment vs medication summary vs medication scheme: there is a lack of detail in the modelling
- medication summary : sort of a view/snapshot on the medication
- medication scheme: digested scheme of a patient's medications
- kmehr MS with a concept of different medication treatments: what contains the list of medication treatment lines ? the medication treatment
- There is a need for examples and compilation to documents
- Therefore it would be useful to start a list with the examples that we need
- psychiatric medication with privacy settings
- medication having same substance used for different indications and different posologies
- distinction between hospital treatment and home therapy
- interactions between home therapy and psychiatric medication
- magistral preparations
- need to see clear example of and difference b/w treatments and summary
- Do we need support from pharmacist ?
- José will ask input from vidis
- Pablo will have a look
- Jens will try to provide input
- Tom H will check
Action items for next meeting
- each one of us to check offline and with his team to continue discussion on treatment lines
- status of approval of medication history : to provide by HL7 Belgium
Next meeting May 25 at 11AM
